Liver Diseases: all 2,094 studies
Page 10 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Delta Radiomics for Liver Function EvaluationStatus unknownNCT05296434
- Percutaneous Versus Endoscopic Ultrasound-guided Liver Biopsy (PEREUS)CompletedNCT05295537Not applicable
- Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)CompletedNCT05292911Phase 1
- Difference in Patterns of Liver Diseases Related Admissions After the Era of DAASStatus unknownNCT05284916
- Impact of Teach Back of Discharge Information in Term of Patient Recall of Information and Patient EngagementCompletedNCT05280171Not applicable
- Genetic Collection ProtocolCompletedNCT05272319
- The Function of PET Molecular Imaging Targeting Fibroblast Activation Protein in the Hepatobiliary MalignanciesStatus unknownNCT05264688
- Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes (TANGO Study)CompletedNCT05259475Not applicable
- Tissue Models for Liver DiseaseCompletedNCT05255042
- Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD IndividualsStatus unknownNCT05245890
- Evaluation of Liver Disease in Individuals Attending Alcohol Abuse Treatment - a Randomized Controlled Pilot TrialCompletedNCT05244720Not applicable
- Impact of Counselling and Visual Aid on Anxiety in Endoscopic PatientsCompletedNCT05241158Not applicable
- An Integrative Model for Palliative Care in End-Stage Liver DiseaseCompletedNCT05238779
- Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant PatientsActive, not recruitingNCT05234190Phase 1/2
- Hybrid Training and Middle AgeCompletedNCT05231564Not applicable
- Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver FibrosisWithdrawnNCT05229640Not applicable
- A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver DysfunctionCompletedNCT05224609Phase 1
- Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouchCompletedNCT05224037Not applicable
- Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.Status unknownNCT05218538
- Healthy Liver - Healthy BrainCompletedNCT05216796Not applicable
- Fruquintinib Hepatic Impairment StudyCompletedNCT05216367Phase 1
- The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney DiseaseStatus unknownNCT05215964
- Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver DiseasesStatus unknownNCT05204602
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy SubjectsWithdrawnNCT05203367Phase 1
- Impact Of Choline in Patients With NAFLDStatus unknownNCT05200156Not applicable
- An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143CompletedNCT05199610Phase 1
- Liver Cancer Prevention Randomized Control TrialActive, not recruitingNCT05196867Not applicable
- Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant RecipientsActive, not recruitingNCT05195125Phase 1
- Identification and Characterization of NAFLD in TurkeyCompletedNCT05194553
- A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseStatus unknownNCT05193201Phase 1
- Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol UseActive, not recruitingNCT05191446Not applicable
- Electrical Impedance Tomography in Fatty Liver DetectionCompletedNCT05189990
- Utilization of MAsS in Patients Undergoing LT for HCCTerminatedNCT05184283
- Tongue Image Database and Diagnostic Model for Digestive Tract Disease DiagnosisCompletedNCT05182983
- High Resolution HBA-MRI Using Deep Learning ReconstructionActive, not recruitingNCT05182099Not applicable
- The Second COVID-19 Wave: Collateral Impact on Patients of Liver DiseaseCompletedNCT05167305
- Shear-wave Elastography Diffuse Liver DiseaseStatus unknownNCT05163132
- An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATLD)WithdrawnNCT05146882Phase 2
- Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver DiseaseWithdrawnNCT05130346Not applicable
- Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)Active, not recruitingNCT05129904
- Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic FunctionTerminatedNCT05126329Phase 1
- Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASHStatus unknownNCT05120557Not applicable
- Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired PatientsCompletedNCT05116826Phase 1
- A Study to Evaluate the Effect of Hepatic Impairment on Lazertinib (JNJ-73841937)CompletedNCT05112952Phase 1
- Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver DiseaseCompletedNCT05107271
- Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.Status unknownNCT05106049
- Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.Status unknownNCT05093218Not applicable
- A Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, DelhiStatus unknownNCT05088044Not applicable
- Oral Docetaxel in Patients With Normal or Impaired Liver FunctionWithdrawnNCT05084456Phase 1
- Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05084404Phase 2
- Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2CompletedNCT05081427
- Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver CirrhosisCompletedNCT05080465Phase 3
- Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function.CompletedNCT05078580Phase 1
- Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty LiverStatus unknownNCT05076058Not applicable
- Effectiveness of Nurse-led Family Intervention on Stress, Engagement With Patient's Care and Satisfaction Among Primary Caregivers of Chronic Liver Disease Patients Admitted in High Dependency Unit of ILBS, New DelhiStatus unknownNCT05073341Not applicable
- A Clinical Trial of XZP-6019 Tablets in Healthy SubjectsStatus unknownNCT05063968Phase 1
- TheraSphere With Durvalumab and Tremelimumab for HCCActive, not recruitingNCT05063565Phase 2
- Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin DiseaseStatus unknownNCT05062967
- Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes MellitusStatus unknownNCT05054712
- HELIO Liver Test Performance Study in China (HEPATIC)CompletedNCT05053412
- Natural History of Non Alcoholic Fatty Liver Disease and Predictors of Advanced FibrosisWithdrawnNCT05050721
- Pre-emptive Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Cystic Fibrosis Related Liver DiseaseCompletedNCT05037643Not applicable
- Effect of Lockdown During COVID 19 Pandemic on Liver Disease and Metabolic Parameters.CompletedNCT05028842
- Diaphragm Ultrasound to Evaluate the Antagonistic Effect of SugammadexStatus unknownNCT05028088Phase 4
- Study to Assess the Pharmacokinetics of Pelacarsen (TQJ230) in Participants With Mild Hepatic Impairment Compared to Matched Healthy ParticipantsCompletedNCT05026996Phase 1
- Prognostic Factors After Liver TransplantationCompletedNCT05018741
- Prevalence of Liver Disease in Patients Dependent on Parenteral NutritionCompletedNCT05011370
- A Single and Repeat Dose Trial in Participants With Hepatic ImpairmentStatus unknownNCT05009680Phase 1/2
- Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver DiseasesStatus unknownNCT05007665
- Alcoholic Liver Disease and the Gut MicrobiomeActive, not recruitingNCT05007470Not applicable
- ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT05006885Phase 1
- Energy Therapy and Meditation Based Practice for Sleep DifficultiesCompletedNCT05003050Not applicable
- A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With PruritusCompletedNCT04999787Phase 2
- Hepatic Manifestations and Effect of Long COVID-19 on Patients With Chronic Liver DiseaseStatus unknownNCT04998214
- Pharmacokinetics Study of FIA586 in Participants With Mild and Moderate Hepatic ImpairmentCompletedNCT04993157Phase 1
- Predicting Obesity Consequences Using Body Measure and Urine MetabolomicsStatus unknownNCT04989062
- "CAP" Fetge Gras. Lifestyle Modification Program in Catalonia.CompletedNCT04988633Not applicable
- Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up StudyCompletedNCT04988230Not applicable
- Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver DiseaseCompletedNCT04988204Not applicable
- COVID-19 and Nonalcoholic Fatty Liver DiseaseCompletedNCT04982328
- Effectiveness of Music Intervention on Anxiety and Physiological Responses in Critical Ill PatientCompletedNCT04977011Not applicable
- CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102)Status unknownNCT04975477
- Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)Active, not recruitingNCT04965259
- Impact of Integrating an Addiction Team on Post Liver Transplantation Survival for Alcohol-related Liver Disease and Its Complications.CompletedNCT04964687
- A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult ParticipantsCompletedNCT04960124Phase 1
- LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver DiseaseCompletedNCT04953143Not applicable
- Clinical, Biochemical and Body Composition Analysis in Assessment of Steatosis in Non Alcoholic Fatty Liver DiseaseStatus unknownNCT04946786
- A Study to Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants With Normal Hepatic FunctionCompletedNCT04942964Phase 1
- Effect of F. Prausnitzii on Glycemic ControlStatus unknownNCT04938843Not applicable
- A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy VolunteersCompletedNCT04931147Phase 1
- Fibrinogen and Intraoperative Bleeding in Liver TransplantCompletedNCT04925843
- Exercise Intervention in Liver Transplant CandidatesStatus unknownNCT04924595Not applicable
- Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective ProcedureStatus unknownNCT04915287Phase 4
- Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic SteatosisCompletedNCT04907721Not applicable
- Avatrombopag in Patients With End-stage Liver Disease and ThrombocytopeniaStatus unknownNCT04906083Phase 4
- Sexual Dysfunction in Patients With Chronic Liver DiseaseStatus unknownNCT04896723
- Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)CompletedNCT04883177
- Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT04882644Not applicable
- Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD)Status unknownNCT04876443
- Electronic Record Assimilation and Subsequent Eradication of Hepatitis CCompletedNCT04873609Not applicable